Welcome to the Biomanufacturing Matchup Event, where biology meets bold ambition. EXPECTED > 200 startups | 200 investors | 1 week of virtual meetings | FreeUPDATE (APR.14) > There are already 250+ startups and 250+ investors registered! From sustainable jet fuel to protein production, from next-gen pharmaceuticals to high-performance biomaterials—there are few limits to what […]

San Francisco Climate Week is around the corner, and the IndieBio team is gearing up for a dynamic week of thought-provoking conversations with leaders at the forefront of climate tech. We’re excited to invite you to three incredible events focused on the intersection of innovation, investment, and impact. Details below: 🤖 Breakthroughs in AI x […]

SOSV’s IndieBio NY just held a demo day at its offices in Manhattan. Fifteen spectacular deep tech founders tackling human and planetary health took the stage in front of a packed audience of investors. The IndieBio NY team made this terrific video to kick off the event and introduce the main deep tech themes of […]

Introducing Deborah Zajac, SOSV’s newest general partner and member of the IndieBio NY team.

Zurich-based Oxyle recently raised a $16M seed round led by 360 Ventures with participation from Axeleo Capital, Founderful and SOSV, according to a report in Forbes. Water supplies around the world are contaminated with “Forever Chemicals,” or the 10,000 perfluoroalkyl and polyfluoroalkyl substances known by the acronym PFAS. They are linked to a sharp increases […]

Rybodyn, Inc. is making waves in biotech with its groundbreaking discovery of a cryptic human proteome and a $4 million pre-seed funding round.

Proton Intelligence has raised a $6.95M seed round to accelerate their work on a continuous potassium monitor that aims revolutionize clinical care for at risk patients.

The past year has been remarkable year for SOSV. In April, we announced SOSV’s $306 million Fund V, our largest yet.

Unibaio wins the $1M grand prize in ESD’s Grow-NY International Food and Agriculture Business Competition

OneSkin closes $7M Series A, accelerating groundbreaking efforts in skin health and longevity